Soft-tissue sarcomas (STS) are a malignant group of soft tissue tumours. STS originate mainly in the ex-traskeletal mesenchymal connective tissue and the mesodermal endothelium. They are characterised by similarities in their pathological appearance and common clinical behaviour. Most STS are highly malignant with a strong tendency to recur locally and a high rate of early distant blood-borne metastases.
KeywordsSarcoma Osteosarcoma Adriamycin Ifosfamide Chondrosarcoma
Unable to display preview. Download preview PDF.
- AJC, American Joint Committee on Cancer (1983) Manual for staging of cancer, 2nd edn. Lippincott, Philadelphia, pp 111–113Google Scholar
- Bramwell VHC, et al. (1987) European experience of adjuvant chemotherapy for soft tissue sarcoma: interim report of a randomized trial of CYVADIC versus control. Proc of the Innisbrook International Symposium on Sarcomas. Oct 1987, Tarpon Springs, Florida, USAGoogle Scholar
- Edmondson JH (1984) Role of adjuvant chemotherapy in the management of patients with soft tissue sarcomas. Cancer Treat Rep 89–101Google Scholar
- Eibler FR (1984) Soft tissue sarcomas of the extremity. Curr Probl Cancer 8: 3–41Google Scholar
- Enneking WF, Spanier SS, Goodman MM (1980) Current concepts review: the surgical staging of musculoskeletal sarcoma. J Bone Joint Surg [Am] 62: 1027–1030Google Scholar
- Hermanek P, Sobin LH (1987) TNM classification of malignant tumours, 4th edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
- Schurette S. et al. (1986) Adriamycin and ifosfamide: a new effective combination in advanced soft tissue sarcomas: preliminary report of phase II study of the EORTC group. Proc Ann Meet Am Soc Clin Oncol 5: 145Google Scholar